Enterprise Value
25.99M
Cash
779K
Avg Qtr Burn
-4.884M
Short % of Float
1.71%
Insider Ownership
9.05%
Institutional Own.
5.09%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NurOwn (autologous MSC-NTF) Details Neurodegenerative disease, Amyotrophic lateral sclerosis | Phase 3 Initiation | |
NurOwn (autologous MSC-NTF) Details Multiple sclerosis | Failed Discontinued |